Lessee, Operating Lease, Liability, to be Paid, Year Four of Regulus Therapeutics Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Regulus Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
Regulus Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was $0.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Regulus Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$0	$0		31 Dec 2024	10-K	13 Mar 2025	2024	FY
Q4 2023	$0	-$277,000	-100%	31 Dec 2023	10-K	21 Mar 2024	2023	FY
Q4 2022	$277,000	-$547,000	-66%	31 Dec 2022	10-K	23 Mar 2023	2022	FY
Q3 2022	$277,000			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$277,000			30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q4 2021	$824,000			31 Dec 2021	10-K	11 Mar 2022	2021	FY
Q2 2019	$1,200,000			30 Jun 2019	10-Q	08 Aug 2019	2019	Q2
Q1 2019	$1,200,000			31 Mar 2019	10-Q	10 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.